ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 189 filers reported holding ACORDA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.92 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $9,000 | -75.0% | 12,056 | -68.9% | 0.00% | – |
| Q1 2020 | $36,000 | -75.0% | 38,705 | -44.8% | 0.00% | – |
| Q4 2019 | $144,000 | -3.4% | 70,120 | +34.2% | 0.00% | – |
| Q3 2019 | $149,000 | -71.0% | 52,235 | -22.1% | 0.00% | – |
| Q2 2019 | $513,000 | +2.8% | 67,086 | +78.6% | 0.00% | – |
| Q1 2019 | $499,000 | -38.5% | 37,560 | -27.8% | 0.00% | -100.0% |
| Q4 2018 | $811,000 | -59.7% | 51,989 | -49.1% | 0.00% | 0.0% |
| Q3 2018 | $2,010,000 | -8.0% | 102,227 | +34.2% | 0.00% | -50.0% |
| Q2 2018 | $2,185,000 | +17.3% | 76,154 | -3.3% | 0.00% | +100.0% |
| Q1 2018 | $1,863,000 | +421.8% | 78,736 | +373.1% | 0.00% | – |
| Q4 2017 | $357,000 | +60.1% | 16,643 | +76.0% | 0.00% | – |
| Q3 2017 | $223,000 | +87.4% | 9,456 | +58.3% | 0.00% | – |
| Q2 2017 | $119,000 | -98.3% | 5,974 | -98.2% | 0.00% | -100.0% |
| Q1 2017 | $7,054,000 | +8.4% | 335,892 | -3.0% | 0.01% | 0.0% |
| Q4 2016 | $6,509,000 | -21.1% | 346,155 | -12.4% | 0.01% | -22.2% |
| Q3 2016 | $8,253,000 | -47.2% | 395,311 | -35.5% | 0.01% | -57.1% |
| Q2 2016 | $15,631,000 | +477.6% | 612,867 | +489.1% | 0.02% | +425.0% |
| Q1 2016 | $2,706,000 | +129.3% | 104,035 | +270.2% | 0.00% | +300.0% |
| Q4 2015 | $1,180,000 | -83.6% | 28,100 | -89.9% | 0.00% | -88.9% |
| Q3 2015 | $7,208,000 | +24755.2% | 277,250 | +31658.3% | 0.01% | – |
| Q2 2015 | $29,000 | -50.0% | 873 | -49.2% | 0.00% | – |
| Q1 2015 | $58,000 | -72.6% | 1,720 | -67.7% | 0.00% | – |
| Q4 2014 | $212,000 | -0.5% | 5,319 | -17.8% | 0.00% | – |
| Q3 2014 | $213,000 | -44.5% | 6,468 | -44.6% | 0.00% | – |
| Q2 2014 | $384,000 | +35.2% | 11,665 | +51.9% | 0.00% | – |
| Q1 2014 | $284,000 | -79.6% | 7,677 | -84.0% | 0.00% | -100.0% |
| Q4 2013 | $1,390,000 | -54.4% | 47,945 | -46.5% | 0.00% | -75.0% |
| Q3 2013 | $3,050,000 | +1.2% | 89,687 | -1.9% | 0.00% | 0.0% |
| Q2 2013 | $3,015,000 | – | 91,379 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |